Edition:
United Kingdom

ProQR Therapeutics NV (PRQR.OQ)

PRQR.OQ on NASDAQ Stock Exchange Global Market

7.15USD
9:00pm BST
Change (% chg)

$0.00 (+0.00%)
Prev Close
$7.15
Open
$7.05
Day's High
$7.25
Day's Low
$7.05
Volume
14,863
Avg. Vol
13,283
52-wk High
$7.45
52-wk Low
$2.78

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.50 -0.334
FY 2017 Dec '17 0.51 -0.393
Sep '17 0.33 -0.416
Jun '17 0.26 -0.474
Mar '17 0.39 -0.446
FY 2016 Dec '16 0.10 -0.378
Sep '16 0.45 -0.434
Jun '16 0.59 -0.427
Mar '16 0.69 -0.437
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 2 0.65 1.00 0.30 --
Quarter Ending Dec-18 2 0.80 1.00 0.60 --
Year Ending Dec-18 2 2.65 3.60 1.70 0.56
Year Ending Dec-19 1 4.50 4.50 4.50 0.00
Earnings (per share)
Quarter Ending Sep-18 2 -0.38 -0.37 -0.39 --
Quarter Ending Dec-18 2 -0.45 -0.38 -0.52 --
Year Ending Dec-18 1 -1.54 -1.54 -1.54 -2.01
Year Ending Dec-19 1 -1.65 -1.65 -1.65 -3.26
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.36 32.76
P/E High - Last 5 Yrs. -- 298.43 45.44
P/E Low - Last 5 Yrs. -- 91.46 24.26
Beta -- 0.93 0.89
Price to Sales (TTM) 79.24 112.59 5.73
Price to Book (MRQ) 2.60 15.55 5.47
Price to Tangible Book (MRQ) 2.61 14.65 7.05
Price to Cash Flow (TTM) -- 72.62 23.29
% Owned Institutions 54.62 14.53 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.51
Dividend Yield - 5 Year Avg -- 0.27 1.52
Dividend 5 Year Growth Rate -- 1.70 5.22
Payout Ratio(TTM) -- 16.36 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -55.01 408.16 8.01
Sales (TTM) vs TTM 1 Yr. Ago -64.75 79.91 5.64
Sales - 5 Yr. Growth Rate -- 32.07 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -11.03 29.00 20.60
EPS (TTM) vs TTM 1 Yr. Ago -24.00 -- --
EPS - 5 Yr. Growth Rate -- 39.51 10.66
Capital Spending - 5 Yr. Growth Rate -- 39.99 15.33

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.92 2.22
Current Ratio (MRQ) 8.22 5.49 3.03
LT Debt to Equity (MRQ) 16.54 34.93 12.51
Total Debt to Equity (MRQ) 16.54 36.74 16.84
Interest Coverage (TTM) -- -101.19 32.64

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.30 54.37
Gross Margin - 5 Yr. Avg. -- 50.70 52.17
EBITD Margin (TTM) -3,241.64 -- --
EBITD - 5 Yr. Avg -- -587.40 10.81
Operating Margin (TTM) -3,331.95 -734.14 4.57
Operating Margin - 5 Yr. Avg. -- -609.01 6.23
Pre-Tax Margin (TTM) -3,376.41 -708.28 5.43
Pre-Tax Margin - 5 Yr. Avg. -- -612.53 6.67
Net Profit Margin (TTM) -3,376.57 -709.68 1.72
Net Profit Margin - 5 Yr. Avg. -- -615.55 2.94
Effective Tax Rate (TTM) -- 23.24 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.56 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) 10,657 23,033,779 860,399,112
Net Income/Employee (TTM) -359,831 3,118,930 101,210,045
Receivable Turnover (TTM) -- 20.76 5.87
Inventory Turnover (TTM) -- 2.48 3.41
Asset Turnover (TTM) 0.02 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -61.65 0.26 11.14
Return on Assets - 5 Yr. Avg. -- 3.71 12.40
Return on Investment (TTM) -68.51 2.21 14.61
Return on Investment - 5 Yr. Avg. -- 2.88 16.14
Return on Equity (TTM) -75.74 3.85 16.34
Return on Equity - 5 Yr. Avg. -- 3.83 17.40
  1 Year 3 Year 5 Year
Sales % -43.49 150.71 --
EPS (TTM) % -87.68 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for ProQR Therapeutics NV

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 48.61%
# of Holders: 39
Total Shares Held: 15,518,810
3 Mo. Net Change: 491,625
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 5
# Reduced Positions: 0
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.